LAB: Labiana Health, S.A. - Summary | Jitta

Labiana Health, S.A.

ESP:LAB

Notice
Stock data is incomplete.
Price
€6.85
Loss Chance
54.1%
2.97JITTA SCORE
389.89%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (43)
Recent Business Performance (56)
Financial Strength (27)
Return to Shareholders (21)
Competitive Advantage (41)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Recent IPOLess than 3 years
Operating MarginInconsistent
Key Stats
Jitta Score
Jitta Line
2.97
389.89%
3.12
562.95%
3.12
562.95%
0.32
100.00%
3.33
> 1,000%
0.96
100.00%
COMPANY DESCRIPTION
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms, bacterial vaccines and biological formats; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contract developments, quality system and manufacturing services. Labiana Health S.A. was founded in 1958 and is based in Pozuelo de Alarcón, Spain.